Dr. Jennifer McVean, MD, is a nationally recognized pediatric endocrinologist and diabetes specialist dedicated to improving the lives of children and families affected by diabetes and endocrine disorders. Diagnosed with Type 1 diabetes at age 11, Dr. McVean brings a unique perspective to patient care by combining her personal experience with extensive medical expertise.
She earned her medical degree from the University of Minnesota Medical School, completed her pediatric residency at the University of Colorado, and pursued a fellowship in Pediatric Endocrinology and Diabetes at the University of Wisconsin. Board-certified in Pediatrics and Pediatric Endocrinology, Dr. McVean has held leadership, academic, and clinical positions with esteemed healthcare organizations, including the University of Minnesota, Children’s Minnesota, and Medtronic Diabetes.
In her current role as Senior Director of Medical Affairs for Medtronic Diabetes, Dr. McVean focuses on advancing diabetes technology and innovation. Her work has contributed to the development of automated insulin delivery systems and continuous glucose monitoring, aiming to improve outcomes for pediatric patients worldwide. Notably, she has been involved in studies demonstrating the benefits of using the MiniMed™ 780G system, which has shown to reduce the burden of diabetes management by improving sleep and glycemic control overnight.
Dr. McVean’s commitment extends beyond clinical practice and research. She actively participates in diabetes advocacy and educational organizations, including the Juvenile Diabetes Research Foundation (JDRF) and the American Diabetes Association (ADA). Her dedication to mentoring, research, education, and community outreach underscores her mission to enhance diabetes awareness, prevention, and treatment.
Through her clinical leadership, research contributions, and work in medical technology, Dr. Jennifer McVean continues to influence the future of diabetes care worldwide. Her mission remains focused on helping individuals with diabetes achieve healthier, more independent lives while advancing innovations that reduce the burden of disease for future generations.
Dr. Jennifer McVean has become a respected voice in the Type 1 Diabetes community through her leadership, advocacy, and commitment to advancing diabetes care. Living with Type 1 Diabetes herself, Dr. McVean brings both personal experience and medical expertise to the search for better treatments and, ultimately, a cure.
Her work has helped accelerate awareness of emerging disease-modifying therapies, early detection programs, advanced insulin delivery systems, and next-generation cell-based treatments that are changing the future of Type 1 Diabetes care. Researchers worldwide are now making significant progress toward therapies that may delay, prevent, or one day eliminate the need for lifelong insulin dependence.
As a physician, educator, and advocate, Dr. McVean continues to support groundbreaking research efforts aimed at preserving insulin-producing cells, improving quality of life, and moving the medical community closer to a world without Type 1 Diabetes. While no definitive cure has yet been approved, the pace of innovation has never been greater, and leaders like Dr. McVean are helping drive that progress forward.
To learn more about Dr. Jennifer McVean and her work, visit her profile at Hudson Physicians.